{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:58:35Z","timestamp":1792796315892,"version":"4.5.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.phrs.2020.104954","type":"journal-article","created":{"date-parts":[[2020,5,31]],"date-time":"2020-05-31T17:44:07Z","timestamp":1590947047000},"page":"104954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Delivery routes for faecal microbiota transplants: Available, anticipated and aspired"],"prefix":"10.1016","volume":"159","author":[{"given":"Monica","family":"Gulati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leander","family":"Corrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indu Pal","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lipika","family":"Chandwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.phrs.2020.104954_bib0005","doi-asserted-by":"crossref","first-page":"E44","DOI":"10.1016\/S1473-3099(19)30569-9","article-title":"Ethical implications of recruiting universal stool donors for faecal microbiota transplantation","volume":"20","author":"Mikail","year":"2020","journal-title":"Lancet Infect. Dis."},{"issue":"03","key":"10.1016\/j.phrs.2020.104954_bib0010","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-2008-1044063","article-title":"Christian Franz Paullini und die hom\u00f6opathische Dreckapotheke","volume":"253","author":"Appell","year":"2008","journal-title":"Allgemeine Hom\u00f6opathische Zeitung"},{"key":"10.1016\/j.phrs.2020.104954_bib0015","series-title":"Heilsame Dreck-Apotheke wie n\u00e4mlich mit Koth un Urin fast alle, ja auch die schwerste griffstigste Krankenheit un bezauberte Sch\u00e4den von Haupt bis zum F\u00fcssen, in un \u00e4usserlich gl\u00fccklich curirt worden","author":"CF","year":"1696"},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.amjms.2018.08.010","article-title":"Current evidence in delivery and therapeutic uses of fecal microbiota transplantation in human diseases\u2014Clostridium difficile disease and beyond","volume":"356","author":"Stripling","year":"2018","journal-title":"Am. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0025","first-page":"854","article-title":"Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis","volume":"44","author":"Eiseman","year":"1958","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0030","first-page":"203","article-title":"Fecal microbiota transplantation: an update","volume":"13","author":"Lichtenstein","year":"2017","journal-title":"Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.phrs.2020.104954_bib0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.5946\/ce.2019.009","article-title":"Fecal microbiota transplantation: an update on clinical practice","volume":"52","author":"Kim","year":"2019","journal-title":"Clin. Endosc."},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0040","first-page":"79","article-title":"Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders","volume":"5","author":"Heath","year":"2018","journal-title":"North. Clin. Istanb."},{"issue":"10","key":"10.1016\/j.phrs.2020.104954_bib0045","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/nu11102291","article-title":"Impact of fecal microbiota transplantation on obesity and metabolic syndrome\u2014a systematic review","volume":"11","author":"Zhang","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.phrs.2020.104954_bib0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2017.12.009","article-title":"Alzheimer\u2019s disease and gut microbiota modifications: the long way between preclinical studies and clinical evidence","volume":"129","author":"Mancuso","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.phrs.2020.104954_bib0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.9758\/cpn.2016.14.3.231","article-title":"Fecal microbiota transplantation and its usage in neuropsychiatric disorders","volume":"14","author":"Evrensel","year":"2016","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"7","key":"10.1016\/j.phrs.2020.104954_bib0060","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/jnr.24616","article-title":"Dysregulation of synaptic pruning as a possible link between intestinal microbiota dysbiosis and neuropsychiatric disorders","volume":"98","author":"Eltokhi","year":"2020","journal-title":"J. Neurosci. Res."},{"issue":"2","key":"10.1016\/j.phrs.2020.104954_bib0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/iub.1969","article-title":"Lung inflammation and disease: a perspective on microbial homeostasis and metabolism","volume":"71","author":"Mendez","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.phrs.2020.104954_bib0070","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fcimb.2020.00009","article-title":"The gut-lung Axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.phrs.2020.104954_bib0075","series-title":"Important Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms","author":"U. FDA","year":"2019"},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0080","first-page":"40","article-title":"Efficacy analysis of fecal microbiota transplantation in the treatment of 406 cases with gastrointestinal disorders","volume":"20","author":"Li","year":"2017","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi= Chin. J. Gastrointestinal Surg."},{"issue":"8","key":"10.1016\/j.phrs.2020.104954_bib0085","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/MCG.0b013e3181dac035","article-title":"Treatment of refractory\/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients","volume":"44","author":"Yoon","year":"2010","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104954_bib0090","first-page":"e52154","article-title":"Fecal microbiota transplantation via colonoscopy for recurrent C. difficile infection","volume":"94","author":"Allegretti","year":"2014","journal-title":"JoVE"},{"issue":"3","key":"10.1016\/j.phrs.2020.104954_bib0095","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/gastro\/gox018","article-title":"Fecal microbiota transplantation for Clostridium difficile infection in patients with ileal pouches","volume":"5","author":"Lan","year":"2017","journal-title":"Gastroenterol. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0100","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/ajg.2011.482","article-title":"Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection","volume":"107","author":"Hamilton","year":"2012","journal-title":"Am. J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104954_bib0105","doi-asserted-by":"crossref","first-page":"975","DOI":"10.5009\/gnl15456","article-title":"Coordinated hospital-home fecal microbiota transplantation via percutaneous endoscopic cecostomy for recurrent steroid-dependent ulcerative colitis","volume":"10","author":"Ni","year":"2016","journal-title":"Gut Liver"},{"issue":"9","key":"10.1016\/j.phrs.2020.104954_bib0110","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/cid\/ciu567","article-title":"Tempered enthusiasm for fecal transplantation?","volume":"59","author":"H\u00f6genauer","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0115","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/367657","article-title":"Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube","volume":"36","author":"Aas","year":"2003","journal-title":"Clin. Infect. Dis."},{"issue":"9","key":"10.1016\/j.phrs.2020.104954_bib0120","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/kjm2.12094","article-title":"Initial experience of fecal microbiota transplantation in gastrointestinal disease: a case series","volume":"35","author":"Wang","year":"2019","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2020.104954_bib0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archinte.172.2.191","article-title":"Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection","volume":"172","author":"Kassam","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.phrs.2020.104954_bib0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.humic.2018.08.004","article-title":"Current and future targets for faecal microbiota transplantation","volume":"11","author":"Mcilroy","year":"2019","journal-title":"Hum. Microbiome J."},{"issue":"7","key":"10.1016\/j.phrs.2020.104954_bib0135","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin. Infect. Dis."},{"issue":"10196","key":"10.1016\/j.phrs.2020.104954_bib0140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0140-6736(19)31266-8","article-title":"The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications","volume":"394","author":"Allegretti","year":"2019","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.phrs.2020.104954_bib0145","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/qjmed\/hcp118","article-title":"Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series","volume":"102","author":"MacConnachie","year":"2009","journal-title":"QJM"},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MPG.0000000000000545","article-title":"Fecal microbiota transplantation via nasogastric tube for recurrent Clostridium difficile infection in pediatric patients","volume":"60","author":"Kronman","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0155","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"Van Nood","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0160","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10620-014-3296-y","article-title":"Intestinal microbiota transplantation, a simple and effective treatment for severe and refractory Clostridium difficile infection","volume":"60","author":"Zainah","year":"2015","journal-title":"Dig. Dis. Sci."},{"issue":"6","key":"10.1016\/j.phrs.2020.104954_bib0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s15010-012-0307-9","article-title":"Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis","volume":"40","author":"Postigo","year":"2012","journal-title":"Infection"},{"key":"10.1016\/j.phrs.2020.104954_bib0170","article-title":"Fecal microbiota transplantation (FMT) with colonoscopy is superior to enema and nasogastric tube while comparable to capsule for the treatment of recurrentClostridioides difficile infection: a systematic review and meta-analysis","author":"Ramai","year":"2020","journal-title":"Dig. Dis. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2020.104954_bib0175","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/00365521.2012.743585","article-title":"Relationship of symptom duration and fecal bacteriotherapy in Clostridium difficile infection-pooled data analysis and a systematic review","volume":"48","author":"Sofi","year":"2013","journal-title":"Scand. J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.phrs.2020.104954_bib0180","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/cid\/ciu135","article-title":"Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study","volume":"58","author":"Youngster","year":"2014","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0185","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","article-title":"Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent Clostridium difficile infection","volume":"156","author":"Hvas","year":"2019","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0190","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jhin.2017.05.004","article-title":"Comparative effectiveness of faecal microbiota transplant by route of administration","volume":"96","author":"Gundacker","year":"2017","journal-title":"J. Hosp. Infect."},{"issue":"44","key":"10.1016\/j.phrs.2020.104954_bib0195","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1556\/OH.2014.30020","article-title":"Experience with fecal microbiota transplantation in the treatment of Clostridium difficile infection","volume":"155","author":"Vigv\u00e1ri","year":"2014","journal-title":"Orv. Hetil."},{"issue":"3","key":"10.1016\/j.phrs.2020.104954_bib0200","first-page":"191","article-title":"Fecal transplantation for the treatment of Clostridium difficile infection","volume":"8","author":"Brandt","year":"2012","journal-title":"Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0205","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/apt.14201","article-title":"Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection","volume":"46","author":"Quraishi","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2020.104954_bib0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MCG.0000000000000511","article-title":"Upper versus lower gastrointestinal delivery for transplantation of fecal microbiota in recurrent or refractory Clostridium difficile infection","volume":"51","author":"Furuya-Kanamori","year":"2017","journal-title":"J. Clin. Gastroenterol."},{"issue":"7","key":"10.1016\/j.phrs.2020.104954_bib0215","first-page":"402","article-title":"Initial experience with fecal microbiota transplantation in Clostridium difficile infection: transplant protocol and preliminary results","volume":"107","author":"Ponte","year":"2015","journal-title":"Revista Espa\u00f1ola de Enfermedades Digestivas"},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0220","article-title":"Fecal microbiota transplantation: is there a role in the eradication of carbapenem-resistant Klebsiella pneumoniae intestinal carriage?","volume":"109","author":"Ponte","year":"2017","journal-title":"Revista Espa\u00f1ola de Enfermedades Digestivas"},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0225","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/apt.13492","article-title":"Systematic review with meta-analysis: long\u2010term outcomes of faecal microbiota transplantation for Clostridium difficile infection","volume":"43","author":"Li","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0230","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2016-313017","article-title":"European consensus conference on faecal microbiota transplantation in clinical practice","volume":"66","author":"Cammarota","year":"2017","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0235","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ajg.2015.81","article-title":"Frozen encapsulated stool in recurrent Clostridium difficile: exploring the role of pills in the treatment hierarchy of fecal microbiota transplant nonresponders","volume":"110","author":"Stollman","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104954_bib0240","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/7395127","article-title":"Efficacy of routine fecal microbiota transplantation for treatment of recurrent Clostridium difficile infection: a retrospective cohort study","volume":"2019","author":"Nowak","year":"2019","journal-title":"Int. J. Microbiol."},{"key":"10.1016\/j.phrs.2020.104954_bib0245","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819843002","article-title":"Cost savings following faecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"12","author":"Dehlholm-Lambertsen","year":"2019","journal-title":"Therap. Adv. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104954_bib0250","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2687605","article-title":"Fecal microbiota transplantation using upper gastrointestinal tract for the treatment of refractory or severe complicated Clostridium difficile infection in elderly patients in poor medical condition: the first study in an Asian country","author":"Gweon","year":"2016","journal-title":"Gastroenterol. Res. Pract."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0255","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/MCG.0000000000000410","article-title":"The long-term efficacy and safety of fecal microbiota transplant for recurrent, severe, and complicated Clostridium difficile infection in 146 elderly individuals","volume":"50","author":"Agrawal","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104954_bib0260","series-title":"1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients with Recurrent Clostridium difficile Infection (CDI)","author":"Hassoun","year":"2018"},{"key":"10.1016\/j.phrs.2020.104954_bib0265","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afaa073","article-title":"Faecal microbiota transplantation as a home therapy to frail older people","author":"J\u00f8rgensen","year":"2020","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.phrs.2020.104954_bib0270","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cgh.2019.04.037","article-title":"Efficacy of fecal microbiota transplantation for Clostridium difficile infection in children","volume":"18","author":"Nicholson","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.phrs.2020.104954_bib0275","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41396-018-0301-z","article-title":"Effect of fecal microbiota transplantation route of administration on gut colonization and host response in preterm pigs","volume":"13","author":"Brunse","year":"2019","journal-title":"ISME J."},{"issue":"2","key":"10.1016\/j.phrs.2020.104954_bib0280","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3892\/br.2014.403","article-title":"Pediatric severe pseudomembranous enteritis treated with fecal microbiota transplantation in a 13-month-old infant","volume":"3","author":"Wang","year":"2015","journal-title":"Biomed. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0285","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/MPG.0000000000000495","article-title":"Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome","volume":"59","author":"Walia","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"2","key":"10.1016\/j.phrs.2020.104954_bib0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/infdis\/jiv766","article-title":"A novel microbiome therapeutic increases gut microbial diversity and prevents recurrent Clostridium difficile infection","volume":"214","author":"Khanna","year":"2016","journal-title":"J. Infect. Dis."},{"issue":"17","key":"10.1016\/j.phrs.2020.104954_bib0295","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1001\/jama.2014.13875","article-title":"Oral, capsulized, frozen fecal microbiota transplantation for relapsing Clostridium difficile infection","volume":"312","author":"Youngster","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0300","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12879-015-0930-z","article-title":"Effectiveness of fecal-derived microbiota transfer using orally administered capsules for recurrent Clostridium difficile infection","volume":"15","author":"Hirsch","year":"2015","journal-title":"BMC Infect. Dis."},{"issue":"20","key":"10.1016\/j.phrs.2020.104954_bib0305","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule\u2013vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection: a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0310","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13054-015-0738-7","article-title":"Successful treatment of severe sepsis and diarrhea after vagotomy utilizing fecal microbiota transplantation: a case report","volume":"19","author":"Li","year":"2015","journal-title":"Crit. Care"},{"issue":"31","key":"10.1016\/j.phrs.2020.104954_bib0315","doi-asserted-by":"crossref","first-page":"e11706","DOI":"10.1097\/MD.0000000000011706","article-title":"Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection","volume":"97","author":"Chehri","year":"2018","journal-title":"Medicine"},{"issue":"8","key":"10.1016\/j.phrs.2020.104954_bib0320","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1053\/j.gastro.2019.03.017","article-title":"Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases","volume":"156","author":"Cohen","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0325","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1053\/j.gastro.2015.03.045","article-title":"Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis","volume":"149","author":"Rossen","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0330","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12876-019-1010-4","article-title":"Fecal microbiota transplantation for ulcerative colitis: a prospective clinical study","volume":"19","author":"Tian","year":"2019","journal-title":"BMC Gastroenterol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104954_bib0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157259","article-title":"Fecal microbiota transplantation for ulcerative colitis: a systematic review and meta-analysis","volume":"11","author":"Shi","year":"2016","journal-title":"PLoS One"},{"issue":"10075","key":"10.1016\/j.phrs.2020.104954_bib0340","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","article-title":"Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial","volume":"389","author":"Paramsothy","year":"2017","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.phrs.2020.104954_bib0345","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/ajg.2013.257","article-title":"Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation","volume":"108","author":"Angelberger","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"23","key":"10.1016\/j.phrs.2020.104954_bib0350","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003765","article-title":"Fecal microbiota transplantation as a novel therapy for ulcerative colitis: a systematic review and meta-analysis","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine"},{"issue":"10","key":"10.1016\/j.phrs.2020.104954_bib0355","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ajg.2012.93","article-title":"The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?","volume":"107","author":"Damman","year":"2012","journal-title":"Am. J. Gastroenterol."},{"issue":"19","key":"10.1016\/j.phrs.2020.104954_bib0360","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000097","article-title":"Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement","volume":"93","author":"Ianiro","year":"2014","journal-title":"Medicine"},{"key":"10.1016\/j.phrs.2020.104954_bib0365","article-title":"Fecal transplantation for treatment of inflammatory bowel disease","volume":"11","author":"Imdad","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0370","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/ecco-jcc\/jjv203","article-title":"Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease","volume":"10","author":"Vermeire","year":"2016","journal-title":"J. Crohns Colitis"},{"issue":"3","key":"10.1016\/j.phrs.2020.104954_bib0375","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1097\/MPG.0000000000000281","article-title":"Fecal microbial transplantation in early-onset colitis: caution advised","volume":"61","author":"Vandenplas","year":"2015","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0380","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/ajg.2015.19","article-title":"Serial fecal microbiota transplantation alters mucosal gene expression in pediatric ulcerative colitis","volume":"110","author":"Kellermayer","year":"2015","journal-title":"Am. J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0385","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/S0016-5085(17)30969-1","article-title":"Short duration, low intensity, pooled fecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial","volume":"152","author":"Costello","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.phrs.2020.104954_bib0390","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1097\/MIB.0b013e31829ea325","article-title":"Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis","volume":"19","author":"Kump","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.phrs.2020.104954_bib0395","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/19490976.2017.1353848","article-title":"The risk of inflammatory bowel disease flares after fecal microbiota transplantation: systematic review and meta-analysis","volume":"8","author":"Qazi","year":"2017","journal-title":"Gut Microbes"},{"issue":"10","key":"10.1016\/j.phrs.2020.104954_bib0400","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjx063","article-title":"Faecal microbiota transplantation for inflammatory bowel disease: a systematic review and meta-analysis","volume":"11","author":"Paramsothy","year":"2017","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0405","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jgh.12727","article-title":"Fecal microbiota transplantation through mid-gut for refractory Crohn\u2019s disease: safety, feasibility, and efficacy trial results","volume":"30","author":"Cui","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2020.104954_bib0410","doi-asserted-by":"crossref","first-page":"E610","DOI":"10.1055\/s-0042-105205","article-title":"Colonic transendoscopic enteral tubing: a novel way of transplanting fecal microbiota","volume":"4","author":"Peng","year":"2016","journal-title":"Endosc. Int. Open"},{"key":"10.1016\/j.phrs.2020.104954_bib0415","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5480961","article-title":"The value of fecal microbiota transplantation in the treatment of ulcerative colitis patients: a systematic review and meta-analysis","volume":"2018","author":"Cao","year":"2018","journal-title":"Gastroenterol. Res. Pract."},{"issue":"7","key":"10.1016\/j.phrs.2020.104954_bib0420","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s40264-019-00809-2","article-title":"Long-Term safety and efficacy of fecal microbiota transplant in active ulcerative colitis","volume":"42","author":"Ding","year":"2019","journal-title":"Drug Saf."},{"issue":"7","key":"10.1016\/j.phrs.2020.104954_bib0425","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/00365529850171666","article-title":"Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment","volume":"33","author":"Gustafsson","year":"1998","journal-title":"Scand. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0430","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s13054-016-1491-2","article-title":"Successful treatment with fecal microbiota transplantation in patients with multiple organ dysfunction syndrome and diarrhea following severe sepsis","volume":"20","author":"Wei","year":"2016","journal-title":"Crit. Care"},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0435","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.3324\/haematol.2016.154351","article-title":"Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease","volume":"102","author":"Spindelboeck","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.phrs.2020.104954_bib0440","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.3389\/fimmu.2018.02195","article-title":"Treating steroid refractory intestinal acute graft-vs.-host disease with fecal microbiota transplantation: a pilot study","volume":"9","author":"Qi","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0445","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy334","article-title":"Recurrent relatively resistant Salmonella infantis infection in two immunocompromised hosts cleared with prolonged antibiotics and fecal microbiota transplantation (FMT)","volume":"6","author":"Torres Soto","year":"2019","journal-title":"Open Forum Infect. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13052-019-0708-9","article-title":"Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report","volume":"45","author":"Zhong","year":"2019","journal-title":"Ital. J. Pediatr."},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0455","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11894-013-0323-7","article-title":"Intestinal microbiota and its role in irritable bowel syndrome (IBS)","volume":"15","author":"\u00d6hman","year":"2013","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2020.104954_bib0460","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5694\/j.1326-5377.1989.tb136704.x","article-title":"Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?","volume":"150","author":"Borody","year":"1989","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.phrs.2020.104954_bib0465","doi-asserted-by":"crossref","DOI":"10.14309\/00000434-201310001-01862","article-title":"Follow-up study of fecal microbiota transplantation (FMT) for the treatment of refractory irritable bowel syndrome (IBS)","volume":"108","author":"Pinn","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2020.104954_bib0470","first-page":"110","article-title":"Fecal microbiota transplantation as a novel therapy for irritable bowel syndrome with predominant diarrhea","volume":"27","author":"Aguilar","year":"2015","journal-title":"Neurogastroenterol. Motil."},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0475","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(15)33291-1","article-title":"Tu2025 Fecal Microbiota transplantation in irritable bowel syndrome with bloating: results from a prospective pilot study","volume":"148","author":"Holvoet","year":"2015","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0480","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1136\/gutjnl-2016-312513","article-title":"Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating","volume":"66","author":"Holvoet","year":"2017","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.phrs.2020.104954_bib0485","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S0016-5085(17)30679-0","article-title":"Fecal microbiota transplantation in irritable bowel syndrome and a randomized placebo-controlled trial","volume":"152","author":"Holster","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000471919","article-title":"Bifidobacterium-rich fecal donor may be a positive predictor for successful fecal microbiota transplantation in patients with irritable bowel syndrome","volume":"96","author":"Mizuno","year":"2017","journal-title":"Digestion"},{"key":"10.1016\/j.phrs.2020.104954_bib0495","first-page":"A","article-title":"P0397 Efficiency of FMT in cases of \u2018Treatment-resistant\u2019IBS","volume":"2","author":"Syzenko","year":"2016","journal-title":"United European Gastroenterol. J."},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0500","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(17)30338-2","article-title":"Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial","volume":"3","author":"Johnsen","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2020.104954_bib0505","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jad.2018.04.038","article-title":"The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: an open-label observational study","volume":"235","author":"Kurokawa","year":"2018","journal-title":"J. Affect. Disord."},{"issue":"6","key":"10.1016\/j.phrs.2020.104954_bib0510","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(18)30860-6","article-title":"617-fecal microbiota transplantation in irritable bowel syndrome with predominant abdominal bloating: results from a double blind, placebo-controlled clinical trial","volume":"154","author":"Holvoet","year":"2018","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.phrs.2020.104954_bib0515","doi-asserted-by":"crossref","first-page":"S-154","DOI":"10.1016\/S0016-5085(18)30932-6","article-title":"742-A double-blind, randomized, placebo-controlled trial of fecal microbiota transplantation capsules (FMTC) for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D)","volume":"154","author":"Aroniadis","year":"2018","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.phrs.2020.104954_bib0520","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1136\/gutjnl-2018-316434","article-title":"Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study","volume":"67","author":"Halkj\u00e6r","year":"2018","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0525","doi-asserted-by":"crossref","first-page":"A563","DOI":"10.1016\/0016-5085(95)26563-5","article-title":"Bacteriotherapy for chronic constipation-a long-term follow-up","volume":"108","author":"Andrews","year":"1995","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.phrs.2020.104954_bib0530","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1002\/ccr3.1798","article-title":"Efficacy of fecal microbiota transplantation in a patient with chronic intractable constipation","volume":"6","author":"Ohara","year":"2018","journal-title":"Clin. Case Rep."},{"issue":"1","key":"10.1016\/j.phrs.2020.104954_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-00612-y","article-title":"Potential role of fecal microbiota from patients with slow transit constipation in the regulation of gastrointestinal motility","volume":"7","author":"Ge","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2020.104954_bib0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171308","article-title":"Fecal microbiota transplantation in patients with slow-transit constipation: a randomized, clinical trial","volume":"12","author":"Tian","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2020.104954_bib0545","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/gastro\/gox036","article-title":"Outcomes and prognostic factors of fecal microbiota transplantation in patients with slow transit constipation: results from a prospective study with long-term follow-up","volume":"6","author":"Ding","year":"2018","journal-title":"Gastroenterol. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2020.104954_bib0550","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s11427-017-9229-1","article-title":"Long-term follow-up of the effects of fecal microbiota transplantation in combination with soluble dietary fiber as a therapeutic regimen in slow transit constipation","volume":"61","author":"Zhang","year":"2018","journal-title":"China Life Sci."},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0555","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1053\/j.gastro.2016.11.010","article-title":"Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection","volume":"152","author":"Ott","year":"2017","journal-title":"Gastroenterology"},{"issue":"Supplement_2","key":"10.1016\/j.phrs.2020.104954_bib0560","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jcag\/gwz006.050","article-title":"A51 effect of lyophilized sterile fecal filtrate vs lyophilized donor stool on recurrent Clostridium difficile infection (RCDI): preliminary results from a randomized, double-blind pilot study","volume":"2","author":"Kao","year":"2019","journal-title":"J. Can. Assoc. Gastroenterol."},{"issue":"4","key":"10.1016\/j.phrs.2020.104954_bib0565","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/gutjnl-2017-313952","article-title":"Bacteriophage transfer during faecal microbiota transplantation in Clostridium difficile infection is associated with treatment outcome","volume":"67","author":"Zuo","year":"2018","journal-title":"Gut"},{"issue":"8","key":"10.1016\/j.phrs.2020.104954_bib0570","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/gutjnl-2017-315281","article-title":"Low eukaryotic viral richness is associated with faecal microbiota transplantation success in patients with UC","volume":"67","author":"Concei\u00e7\u00e3o-Neto","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.phrs.2020.104954_bib0575","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2019-320005","article-title":"Faecal virome transplantation decreases symptoms of type 2 diabetes and obesity in a murine model","author":"Rasmussen","year":"2020","journal-title":"Gut"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820312627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661820312627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:15:00Z","timestamp":1760912100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661820312627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":115,"alternative-id":["S1043661820312627"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104954","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery routes for faecal microbiota transplants: Available, anticipated and aspired","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2020.104954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104954"}}